A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1991-10

AUTHORS

N M Bleehen, S P Stenning

ABSTRACT

A total of 474 adult patients with malignant glioma (astrocytoma) grade 3 or 4 were randomised into an MRC study (BR2) comparing 45 Gy (in 20 fractions over 4 weeks) with 60 Gy (in 30 fractions over 6 weeks) of radiotherapy given post-operatively. Using 2:1 randomisation, 318 patients were allocated the 60 Gy course and 156 the 45 Gy course. Adjuvant chemotherapy was not given. The results show that a 60 Gy course produces a modest lengthening of progression-free and overall survival. They suggest a statistically significant prolongation of median survival from 9 months in the 45 Gy group to 12 months in the 60 Gy group (hazard ratio = 0.75, chi 2 = 7.36, d.f. = 1, P = 0.007). Over 80% of patients reported no morbidity from the radiotherapy, and there was no evidence of increased short-term morbidity in the higher dose group. Late morbidity was not assessed. A prognostic index defined in a previous MRC study was validated in this new cohort. It identifies a group of patients (20% of the total) with a 2 year survival rate of 28% (95% confidence interval 19% to 38%). It was apparent that the survival advantage to the higher dose was maintained even in the poorest prognostic groups defined by this index. More... »

PAGES

769

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bjc.1991.396

DOI

http://dx.doi.org/10.1038/bjc.1991.396

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1047087251

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/1654987


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glioblastoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neurologic Examination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiotherapy Dosage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "MRC Centre", 
          "id": "https://www.grid.ac/institutes/grid.415042.6", 
          "name": [
            "MRC Clinical Oncology and Radiotherapeutics Unit, MRC Centre, Cambridge, UK."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bleehen", 
        "givenName": "N M", 
        "id": "sg:person.0642762376.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642762376.72"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Stenning", 
        "givenName": "S P", 
        "id": "sg:person.01101002123.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101002123.21"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/bjc.1987.161", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000467391", 
          "https://doi.org/10.1038/bjc.1987.161"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1987.161", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000467391", 
          "https://doi.org/10.1038/bjc.1987.161"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1227/00006123-197909000-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002269448"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(89)90936-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009059085"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(89)90518-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010757788"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19891001)64:7<1409::aid-cncr2820640707>3.0.co;2-r", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011944579"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm195112062452301", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012949677"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19830915)52:6<997::aid-cncr2820520612>3.0.co;2-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013616559"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(89)90548-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015523289"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19850815)56:4<758::aid-cncr2820560410>3.0.co;2-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022904279"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(79)90553-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038111899"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/sim.4780071109", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038327845"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/sim.4780010204", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042510484"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm198012043032303", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043189989"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(81)90436-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048981726"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(79)90554-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049823550"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(89)90941-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052200951"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(85)90068-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053187828"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1259/0007-1285-62-734-158", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064557390"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2214/ajr.126.3.481", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069308402"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/jns.1978.49.3.0333", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071091575"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/jns.1978.49.3.0333", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071091575"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/jns.1978.49.3.0333", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071091575"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076033077", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081686757", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082159516", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1991-10", 
    "datePublishedReg": "1991-10-01", 
    "description": "A total of 474 adult patients with malignant glioma (astrocytoma) grade 3 or 4 were randomised into an MRC study (BR2) comparing 45 Gy (in 20 fractions over 4 weeks) with 60 Gy (in 30 fractions over 6 weeks) of radiotherapy given post-operatively. Using 2:1 randomisation, 318 patients were allocated the 60 Gy course and 156 the 45 Gy course. Adjuvant chemotherapy was not given. The results show that a 60 Gy course produces a modest lengthening of progression-free and overall survival. They suggest a statistically significant prolongation of median survival from 9 months in the 45 Gy group to 12 months in the 60 Gy group (hazard ratio = 0.75, chi 2 = 7.36, d.f. = 1, P = 0.007). Over 80% of patients reported no morbidity from the radiotherapy, and there was no evidence of increased short-term morbidity in the higher dose group. Late morbidity was not assessed. A prognostic index defined in a previous MRC study was validated in this new cohort. It identifies a group of patients (20% of the total) with a 2 year survival rate of 28% (95% confidence interval 19% to 38%). It was apparent that the survival advantage to the higher dose was maintained even in the poorest prognostic groups defined by this index.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/bjc.1991.396", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "64"
      }
    ], 
    "name": "A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma", 
    "pagination": "769", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "e04f386db33647b1478673c71b3e644ea2d7169d7188ccaaaaaa4e0fd0a525b9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "1654987"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bjc.1991.396"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1047087251"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bjc.1991.396", 
      "https://app.dimensions.ai/details/publication/pub.1047087251"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000359_0000000359/records_29200_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/bjc1991396"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.1991.396'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.1991.396'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.1991.396'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.1991.396'


 

This table displays all metadata directly associated to this object as RDF triples.

182 TRIPLES      21 PREDICATES      62 URIs      31 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bjc.1991.396 schema:about N410a93d3fb5744df831063550531c58d
2 N5360e15abc0d4df38252882c27e92c85
3 N72520cbb85d54167a91850b6737ddb26
4 Nb42c4206052b41bfafd7936e04fb7eed
5 Ncf275d471a16491a9f8581028421cf15
6 Ncfb7507f60094475a3f96dc6a87b08e9
7 Nddaa4bc8cb44429ab6b68b97b23680db
8 Nf859ab473ae74fd29a2a518f2620c77f
9 Nfa437240ef084c7280c8d3949f5ea054
10 Nfe1a3532b9c4408387fb864b68b4f56f
11 anzsrc-for:11
12 anzsrc-for:1112
13 schema:author N01aefe03f87346c6bb353895699f6054
14 schema:citation sg:pub.10.1038/bjc.1987.161
15 https://app.dimensions.ai/details/publication/pub.1076033077
16 https://app.dimensions.ai/details/publication/pub.1081686757
17 https://app.dimensions.ai/details/publication/pub.1082159516
18 https://doi.org/10.1002/1097-0142(19830915)52:6<997::aid-cncr2820520612>3.0.co;2-2
19 https://doi.org/10.1002/1097-0142(19850815)56:4<758::aid-cncr2820560410>3.0.co;2-2
20 https://doi.org/10.1002/1097-0142(19891001)64:7<1409::aid-cncr2820640707>3.0.co;2-r
21 https://doi.org/10.1002/sim.4780010204
22 https://doi.org/10.1002/sim.4780071109
23 https://doi.org/10.1016/0360-3016(79)90553-4
24 https://doi.org/10.1016/0360-3016(79)90554-6
25 https://doi.org/10.1016/0360-3016(81)90436-3
26 https://doi.org/10.1016/0360-3016(85)90068-9
27 https://doi.org/10.1016/0360-3016(89)90518-x
28 https://doi.org/10.1016/0360-3016(89)90548-8
29 https://doi.org/10.1016/0360-3016(89)90936-x
30 https://doi.org/10.1016/0360-3016(89)90941-3
31 https://doi.org/10.1056/nejm195112062452301
32 https://doi.org/10.1056/nejm198012043032303
33 https://doi.org/10.1227/00006123-197909000-00001
34 https://doi.org/10.1259/0007-1285-62-734-158
35 https://doi.org/10.2214/ajr.126.3.481
36 https://doi.org/10.3171/jns.1978.49.3.0333
37 schema:datePublished 1991-10
38 schema:datePublishedReg 1991-10-01
39 schema:description A total of 474 adult patients with malignant glioma (astrocytoma) grade 3 or 4 were randomised into an MRC study (BR2) comparing 45 Gy (in 20 fractions over 4 weeks) with 60 Gy (in 30 fractions over 6 weeks) of radiotherapy given post-operatively. Using 2:1 randomisation, 318 patients were allocated the 60 Gy course and 156 the 45 Gy course. Adjuvant chemotherapy was not given. The results show that a 60 Gy course produces a modest lengthening of progression-free and overall survival. They suggest a statistically significant prolongation of median survival from 9 months in the 45 Gy group to 12 months in the 60 Gy group (hazard ratio = 0.75, chi 2 = 7.36, d.f. = 1, P = 0.007). Over 80% of patients reported no morbidity from the radiotherapy, and there was no evidence of increased short-term morbidity in the higher dose group. Late morbidity was not assessed. A prognostic index defined in a previous MRC study was validated in this new cohort. It identifies a group of patients (20% of the total) with a 2 year survival rate of 28% (95% confidence interval 19% to 38%). It was apparent that the survival advantage to the higher dose was maintained even in the poorest prognostic groups defined by this index.
40 schema:genre research_article
41 schema:inLanguage en
42 schema:isAccessibleForFree true
43 schema:isPartOf N429459549b784c13a8b281b2f0caf767
44 N8614c0bf03ac4165b9c40dc2c8c8e832
45 sg:journal.1017082
46 schema:name A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma
47 schema:pagination 769
48 schema:productId N025f18c10ed547f8ace0924c8347bec6
49 N10e5b7cba1d044b4af21de96f6ee6c84
50 N30ed109f9bc24e8f8371f0c1f035b880
51 Nac031f700db64184969b050b23065e73
52 Nfb73d6e7f7154d5ba2b5059c654f7200
53 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047087251
54 https://doi.org/10.1038/bjc.1991.396
55 schema:sdDatePublished 2019-04-11T11:54
56 schema:sdLicense https://scigraph.springernature.com/explorer/license/
57 schema:sdPublisher Na9593687465e459b9a08749faacf063e
58 schema:url https://www.nature.com/articles/bjc1991396
59 sgo:license sg:explorer/license/
60 sgo:sdDataset articles
61 rdf:type schema:ScholarlyArticle
62 N01aefe03f87346c6bb353895699f6054 rdf:first sg:person.0642762376.72
63 rdf:rest N5ae58ab1c1ee4e7f9edf038758820fd2
64 N025f18c10ed547f8ace0924c8347bec6 schema:name dimensions_id
65 schema:value pub.1047087251
66 rdf:type schema:PropertyValue
67 N10e5b7cba1d044b4af21de96f6ee6c84 schema:name readcube_id
68 schema:value e04f386db33647b1478673c71b3e644ea2d7169d7188ccaaaaaa4e0fd0a525b9
69 rdf:type schema:PropertyValue
70 N30ed109f9bc24e8f8371f0c1f035b880 schema:name pubmed_id
71 schema:value 1654987
72 rdf:type schema:PropertyValue
73 N410a93d3fb5744df831063550531c58d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Humans
75 rdf:type schema:DefinedTerm
76 N429459549b784c13a8b281b2f0caf767 schema:volumeNumber 64
77 rdf:type schema:PublicationVolume
78 N5360e15abc0d4df38252882c27e92c85 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Glioblastoma
80 rdf:type schema:DefinedTerm
81 N5ae58ab1c1ee4e7f9edf038758820fd2 rdf:first sg:person.01101002123.21
82 rdf:rest rdf:nil
83 N72520cbb85d54167a91850b6737ddb26 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Radiotherapy Dosage
85 rdf:type schema:DefinedTerm
86 N8614c0bf03ac4165b9c40dc2c8c8e832 schema:issueNumber 4
87 rdf:type schema:PublicationIssue
88 Na9593687465e459b9a08749faacf063e schema:name Springer Nature - SN SciGraph project
89 rdf:type schema:Organization
90 Nac031f700db64184969b050b23065e73 schema:name doi
91 schema:value 10.1038/bjc.1991.396
92 rdf:type schema:PropertyValue
93 Nb42c4206052b41bfafd7936e04fb7eed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Brain Neoplasms
95 rdf:type schema:DefinedTerm
96 Ncf275d471a16491a9f8581028421cf15 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Aged
98 rdf:type schema:DefinedTerm
99 Ncfb7507f60094475a3f96dc6a87b08e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Middle Aged
101 rdf:type schema:DefinedTerm
102 Nddaa4bc8cb44429ab6b68b97b23680db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Adult
104 rdf:type schema:DefinedTerm
105 Nf859ab473ae74fd29a2a518f2620c77f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Neurologic Examination
107 rdf:type schema:DefinedTerm
108 Nfa437240ef084c7280c8d3949f5ea054 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Prognosis
110 rdf:type schema:DefinedTerm
111 Nfb73d6e7f7154d5ba2b5059c654f7200 schema:name nlm_unique_id
112 schema:value 0370635
113 rdf:type schema:PropertyValue
114 Nfe1a3532b9c4408387fb864b68b4f56f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Survival Analysis
116 rdf:type schema:DefinedTerm
117 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
118 schema:name Medical and Health Sciences
119 rdf:type schema:DefinedTerm
120 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
121 schema:name Oncology and Carcinogenesis
122 rdf:type schema:DefinedTerm
123 sg:journal.1017082 schema:issn 0007-0920
124 1532-1827
125 schema:name British Journal of Cancer
126 rdf:type schema:Periodical
127 sg:person.01101002123.21 schema:familyName Stenning
128 schema:givenName S P
129 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101002123.21
130 rdf:type schema:Person
131 sg:person.0642762376.72 schema:affiliation https://www.grid.ac/institutes/grid.415042.6
132 schema:familyName Bleehen
133 schema:givenName N M
134 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642762376.72
135 rdf:type schema:Person
136 sg:pub.10.1038/bjc.1987.161 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000467391
137 https://doi.org/10.1038/bjc.1987.161
138 rdf:type schema:CreativeWork
139 https://app.dimensions.ai/details/publication/pub.1076033077 schema:CreativeWork
140 https://app.dimensions.ai/details/publication/pub.1081686757 schema:CreativeWork
141 https://app.dimensions.ai/details/publication/pub.1082159516 schema:CreativeWork
142 https://doi.org/10.1002/1097-0142(19830915)52:6<997::aid-cncr2820520612>3.0.co;2-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013616559
143 rdf:type schema:CreativeWork
144 https://doi.org/10.1002/1097-0142(19850815)56:4<758::aid-cncr2820560410>3.0.co;2-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022904279
145 rdf:type schema:CreativeWork
146 https://doi.org/10.1002/1097-0142(19891001)64:7<1409::aid-cncr2820640707>3.0.co;2-r schema:sameAs https://app.dimensions.ai/details/publication/pub.1011944579
147 rdf:type schema:CreativeWork
148 https://doi.org/10.1002/sim.4780010204 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042510484
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1002/sim.4780071109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038327845
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1016/0360-3016(79)90553-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038111899
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1016/0360-3016(79)90554-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049823550
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1016/0360-3016(81)90436-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048981726
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1016/0360-3016(85)90068-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053187828
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1016/0360-3016(89)90518-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1010757788
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1016/0360-3016(89)90548-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015523289
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1016/0360-3016(89)90936-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1009059085
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1016/0360-3016(89)90941-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052200951
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1056/nejm195112062452301 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012949677
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1056/nejm198012043032303 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043189989
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1227/00006123-197909000-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002269448
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1259/0007-1285-62-734-158 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064557390
175 rdf:type schema:CreativeWork
176 https://doi.org/10.2214/ajr.126.3.481 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069308402
177 rdf:type schema:CreativeWork
178 https://doi.org/10.3171/jns.1978.49.3.0333 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071091575
179 rdf:type schema:CreativeWork
180 https://www.grid.ac/institutes/grid.415042.6 schema:alternateName MRC Centre
181 schema:name MRC Clinical Oncology and Radiotherapeutics Unit, MRC Centre, Cambridge, UK.
182 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...